Skip to main content
Tags: Dexamethasone | steroid | COVID-19 alternative treatment for the severely ill

Benefits of Higher Doses of Dexamethasone to be Tested in Severe COVID-19

Dexamethasone steroid
Dexamethasone, available at an Omaha, Neb. pharmacy. New studies confirm that cheap steroid drugs such as this improve survival for severely ill COVID-19 patients. (AP)

Thursday, 30 December 2021 11:27 AM EST

British scientists said https://www.recoverytrial.net/news/recovery-trial-to-investigate-whether-higher-doses-of-dexamethasone-deliver-greater-benefit-for-patients-with-severe-covid-19?ref=image on Thursday they would study whether higher doses of a cheap and widely used steroid called dexamethasone will work better for patients with severe COVID-19 compared with current doses being given.

Last year, the same scientists conducting the large trial, dubbed RECOVERY, showed that dexamethasone was able to save the lives of COVID-19 patients in what was called a "major breakthrough" in the coronavirus pandemic.

© 2025 Thomson/Reuters. All rights reserved.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.

StreetTalk
British scientists said Thursday they would study whether higher doses of a cheap and widely used steroid, Dexamethasone, could help fight COVID-19
Dexamethasone, steroid, COVID-19 alternative treatment for the severely ill
69
2021-27-30
Thursday, 30 December 2021 11:27 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© 2025 Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© 2025 Newsmax Media, Inc.
All Rights Reserved